The opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The opportunities and challenges of the disease-modifying immunotherapy for type 1 diabetes: A systematic review and meta-analysis

Published:2024-05 Issue: Volume:203 Page:107157
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Lin Chu,Hu Suiyuan,Cai Xiaoling,Lv Fang,Yang Wenjia,Liu Geling,Yang Xiaolin,Ji Linong

Funder

Natural Science Foundation of Beijing Municipality

National Natural Science Foundation of China

Publisher

Elsevier BV

Reference55 articles.

1. Immunotherapy for type 1 diabetes;Frumento;J. Endocrinol. Invest.,2017

2. Immunotherapy: building a bridge to a cure for type 1 diabetes;Bluestone;Science,2021

3. New frontiers in the treatment of type 1 diabetes;Warshauer;Cell Metab.,2020

4. Endotypes in T1D: B lymphocytes and early onset;Smith;Curr. Opin. Endocrinol. Diabetes Obes.,2020

5. Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial;Feutren;Lancet,1986

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can type 1 diabetes be prevented or reversed?;Journal of Diabetes;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP